By unraveling the genetic code of viruses, genome sequencing offers a new era for aquatic virus ecology giving access to ecological function of viruses on an unprecedented scale. Although this chapter starts with the suggestion to that virus genome sequencing should be conducted professionally if financially feasible, we essentially try and guide the reader through some of the procedures that will direct a novice through a genome sequencing project. Arguably, the most important recommendation is to start with as high purity virus nucleic acid as possible. We use the adage, junk in equals junk out. Once sequence information is obtained, there is plenty of free, user-friendly software available to help build, annotate, and then compare sequence data. Acquiring metadata is another important aspect that is not often considered when embarking on a genome project. A new initiative by the Genomic Standards Consortium has introduced Minimum Information about a Genome Sequence (MIGS) that allows standardization of the way the data are collected to make it useful for downstream post-genomic analyses. Most viruses sequenced to date have produced surprises, and there is more to come from the other 10 31 viruses still to be sequenced. This chapter focuses on sequencing purified virus isolates rather than virus metagenomes.
Introduction
By way of a preface, this is not a detailed list of step-by-step methods on how to sequence a virus genome. Sequencing projects, particularly for large DNA viruses (100 kb-1200 kb), are significant undertakings for any lab-based project, and the magnitude of such an onerous task is often underestimated. Here, a sequencing project is defined as all the steps from obtaining a clonal virus isolate through to generation of a completely annotated virus genome. The first question to ask is whether it is financially feasible to get your virus of choice sequenced by a professional facility, i.e., large-scale, high throughput sequencing and bioinformatics facilities. It takes several skill sets and some dedicated expensive equipment to do the job efficiently, a facility not often afforded by a standard aquatic virology laboratory. Exceptions to this are smaller-scale sequencing projects (1 kb-50 kb) such as the small RNA-virus genomes (Lang et al. 2004; Shirai et al. 2008) or some of the smaller, straightforward (e.g., no extensive repeat regions) DNA viruses (Rohwer et al. 2000) . With an increase in new technologies such as 454 (www.454.com), high throughput mass sequencing is becoming more accessible. However, it is still expensive to sequence a single virus genome unless you work together with other researchers to get several viruses on a single run or can negotiate with a facility to use up spare capacity on a high throughput run. The first swathe of sequence data are only a starting point, and although you can get 99% of the genome sequence very quickly, i.e., within 1-2 weeks (Lander and Waterman 1988) , finishing the genome can take up to 95% of the time and budget of an entire sequencing project. In this chapter, we will discuss some of the options when considering the practicality of finishing a virus genome. Clearly, there will be projects on a tight budget that will want to attempt to glean basic sequence information to help develop hypotheses on their viruses. For this, we will provide some basic protocols with Web links and citations to similar projects. This chapter will also explore some of the thinking behind why sequencing a genome should be considered, we will provide an assessment of some of the current techniques and explore how sequence data can be verified once a basic genome annotation has been conducted. Guidelines for collecting metadata associated with the genomes will also be provided as metadata is increasingly important as more viral genomes are sequenced and comparative analyses become feasible. Verification of functional assignment (annotation) is essentially how characterization is defined in this chapter-a much more significant process than the grunt of obtaining the sequence data.
Materials and procedures
Before embarking down the road of virus genome sequencing and annotation, a number of key validation checks should be made:
• Make every effort to start with a clonal and axenic isolate.
Why clonal? Mutation rates in viruses are known to be very high, especially when compared with its cellular hosts, and because the progeny of a single infection event may lead to the production of many variants of the original, it is, therefore, imperative not to complicate the sequence analysis even further by starting off with a mixture of similar genotypes. This can be done by performing either dilution to extinction (Nagasaki and Bratbak 2010, this volume) or plaque assay (Schroeder et al. 2002) experiments. Why axenic? Bacterial sequence contamination is a major problem when sequencing novel genomes. Many sequencing programs have come unstuck because of this very issue. Consequently, give yourself every opportunity of generating sequencing information of your virus by starting off with a well-defined clean system. • Aim to get a large starting quantity of virus. Sequencing protocols are very wasteful, so it is of utmost importance that large quantities of virus, and thus genomic material, be produced (a minimum of 100 ng, though ideally aim for up to 10 µg). Ideally, this needs to be done in one single event from the same starting virus inoculum (i.e., from a clonal virus preparation such as a plaque resuspension). This is to avoid amplifying variants of the original generated by successive and continuous re-inoculation. • Determine an efficient virus concentration protocol (Lawrence and Steward 2010, this volume) . Before proceeding to the next step of extracting virus nucleic acids, it is best to test whether you have any carry over of cellular genomes. This can be easily achieved by using universal ribosomal DNA primer sets. If these PCRs produce positive results, treat your virus concentrate with commercially available nucleases. Since virus nucleic acids are still protected by their capsid, this treatment will have little or no effect on its genome. However, do remember to inactivate the enzymes before proceeding to the nucleic acid extraction phase.
• Nucleic acid quality assessment. Test the quality of the nucleic acids generated using either PCR or restriction digestion. This will help determine if your nucleic acid is suitable for downstream sequencing. Once the initial validation has been done, you can proceed with the assurance that you have done everything possible to mitigate sources of producing junk sequence data. The next few steps entail the extraction and manipulation of nucleic acids, depending on the format available to you:
• Nucleic acid preparation. The choice of nucleic acid extraction will depend on the type of virus genome (RNA or DNA, ss or ds), the quantity and quality produced by the method, and the budget available to you. There are a number of commercially available kits (e.g., Qiagen) that will perform a perfectly adequate job. Alternatively, the universally tried and tested phenol-chloroform method for nucleic acid extraction (Lawrence and Steward 2010, this volume) normally delivers good results. • Nucleic acid random fragmentation. Depending upon the size of the genome and sequencing strategy used, fragmentation may be necessary. For larger dsDNA viruses (>100 kb), the nucleic acids will need to be fragmented into smaller clonable sizes (e.g., 1-4 kb) for shotgun cloning and Sanger-based sequencing. This can be done enzymatically by controlled DNaseI treatment (Rohwer et al. 2000) or physically by sonication (Wilson et al. 2005) . DNaseI treatment-Generation of DNA fragments by DNase digestion involves digesting DNA for a range of times, then picking the time that gives optimal-sized DNA fragments (typically 1000-4000 bp). In a 50 µL reaction volume, resuspend 8 µg DNA in 50 mM Tris·HCl (pH 7.6), 10 mM MnCl 2 , 100 µg mL -1 bovine serum albumin, and 0.01 SU mL -1 DNase I. Remove 5 µL aliquots (adding to 45 µL TE buffer, pH7.6) 0, 0.5, 1, 2, 5, 10, 15, and 30 min after addition of the digestion mixture and immediately transfer to a tube containing 25 µL Tris-buffered (pH 7.0) phenol (typically the shorter incubations, up to 2 min, give optimally sized fragments). After a phenol:chloroform (1:1) and two chloroform extractions, precipitate the fragmented DNA, wash with 70% ethanol, and dry. Resuspend fragmented DNA in 23 µL of Blunt-ending Mix (100 µM dNTPs, 1 × T4 DNA Pol Buffer) and heat at 65°C for 30 min to resuspend DNA and inactivate any DNase I that was carried over. After cooling to room temperature, add 2.5 U Klenow fragment and 5 U T4 DNA polymerase then incubate the reaction at 37°C for 1 h. The fragmented and blunt-ended virus DNA can be run on a 1% agarose gel prior to excising fragments in the 1000-4000 bp range using a standard gel extraction procedures before downstream cloning (NB do not excise fragments smaller than 1000 kb, as downstream cloning will preferentially clone the smaller fragments).
Sonication-Generation of DNA fragments by sonication is performed by placing a microcentrifuge tube containing the buffered DNA sample into an ice-water bath in a cup-horn sonicator. Sonication is conducted for a varying number of 10-s bursts using maximum output and continuous power. Exact conditions for sonication should be empirically determined for a given DNA sample before a preparative sonication is performed. Typically, 100 µg DNA in TE buffer is split into 10 aliquots of 35 µL; 5 are subjected to sonication for increasing numbers of 10 s bursts. Aliquots from each time point are run on an agarose gel to determine optimal-sized DNA fragments (1-4 kb). Once optimal sonication conditions are determined, the remaining 5 aliquots (approximately 8 µg) are sonicated according to those predetermined conditions. DNA can be blunt-ended and size-selected as above prior to downstream cloning.
• Cloning. If newer "next generation sequencing" (see below) options are chosen, any nucleic acid fragmentation or cloning will be conducted by the sequencing facility. Fragmented DNA can be cloned into a wide range of commercially available cloning vectors (e.g., www.promega.com/vectors/cloning_vectors.htm) and/or cloning kits that are available from a wide range of molecular reagents companies (e.g., Promega, Invitrogen, New England Biolabs) that make cloning almost fool-proof. However, remember that cloning procedures work best with high purity insert DNA. It is worth checking the quality of DNA inserts with A260/280 ratios prior to cloning with specific spectrophotometry devices such as NanoDrop (www.nanodrop.com). Smaller DNA or RNA genomes can be cloned whole in specifically designed bacterial artificial chromosome (BAC)-or Yeast Artificial Chromosome (YAC)-based cloning and sequencing vectors, EPICENTRE Biotechnologies is one company that provides a range of options for this (www.epibio.com). Clones can then be sequenced directly, usually using Sanger-based technology (for basic explanation and animation, see http://www.dnai.org/text/mediashowcase/ index2.html?id = 552). • Sequencing. For laboratory-based 'in-house' projects, clone libraries (or PCR products) are typically run with Sangerbased technology. A search of Web sites reveals numerous tips and protocols for improving reads and reducing the cost of sequencing (typically by diluting sequencing enzyme) (e.g., www.nucleics.com). Note the first tip on this site is "Use clean DNA" (junk in = junk out!). If the sequencing project can afford to send DNA directly to a sequencing facility, there are numerous options currently available, from Sanger-based sequencing services to the new generation high throughput services: • Sanger-based sequencing. This technology utilizes DNA polymerase and chain terminating fluorescently bases to create four series of labeled DNA fragments. Sequencing platforms (e.g., ABI & Beckman) capable of resolving these fragments can accurately and efficiently resolve on average ~700-800 bp. Therefore, M13 E. coli based vectors are routinely used to create ~1 kb size clone libraries. The amount of sequence generated is dependent on the size of the virus genome. The general rule of thumb is to generate sequence data of at least 8-fold coverage of your genome. This approach will provide up to 99% coverage of your genome, and then finishing approaches will be required to obtain a full genome (see below). • 454 Sequencing Technology (Roche's Genome Sequencer FLX system; www.454.com). Pyrosequencing is based on a method developed by Ronaghi et al. (1996) and uses enzyme-mediated luminescence during DNA synthesis. The 454 sample preparation first relies on fragmentation of the genomic DNA followed by binding each fragment to a microscopic bead. Pyrosequencing is then used to determine the sequence of each bead-associated DNA fragment. This technology can produce sequence reads of around 200-400 bp, providing around 80-120 Mb per run. The plate platform design of 454 allows the utility of splitting and/or dividing plates, a cost-saving measure that does not appear to be available for other technologies. 454 has been successfully used for finishing or genome assembly purposes (see below). • Illumina's Solexa technology (www.illumina.com). The second commercially available next-generation technology also fragments genomic DNA, which is then ligated to a glass surface where bridge amplification creates multiple clusters of identical sequences (Bentley et al. 2008 ). These then go on to be sequenced by a synthesis step using fluorescently labeled terminators with imaging following each successive base addition. The read lengths are much shorter than those from 454's instrument (~35 bp), therefore this technology is not appropriate for de novo sequencing. However, it comes into its own if you have a genome to align the sequence against as each run (flowcell with 8 channels) produces many times more reads than 454. • SOLiD technology (ABI) (http://www3.appliedbiosystems.com/ AB_Home/applicationstechnologies/SOLiDSystemSequencing/ index.htm). This most recent addition to the next-generation sequencing platforms amplifies fragmented genomic DNA by emulsion PCR on beads, followed by cyclic array (polony) sequencing (Shendure et al. 2005 (Field et al. 2008) , an ongoing process that has the intent of promoting community participation in its development and discussing the resources that will be required to develop improved mechanisms of metadata capture and exchange. It is worth checking the GSC Web portal (URL above) for continuous updates in MIGS implementation. Example metadata required for MIGS compliancy include (but is not limited to) environmental parameters (e.g., location of isolation, physicochemical parameters, type of habitat), pathogenicity parameters; propagation conditions, treatment during collection, nucleic acid extraction procedures, and sequencing procedures (e.g., see example MIGS compliant report in Figure 1 ). An excellent example of the application of MIGS and use of metadata for comparative analysis and annotation of all publicly available genomes (including viruses) can be found at the Integrated Microbial Genomes (IMG) Web portal (http://img.jgi.doe.gov/cgi-bin/w/main.cgi) (Markowitz et al. 2007) . It is a user-friendly interface allowing navigation of genome data along its three key dimensions (genes, genomes, and functions), and groups together the main comparative analysis tools.
• Annotation. This is often the most intimidating aspect of the process-making sense of all that sequence! Arguably the main reason for the anxiety is the enormity of the task at hand. To alleviate this unwelcome uncertainty of "will I be able to recognize any of the genes?" or "what if I miss genes?" in my new uncharted virome, the ever-growing field of bioinformatics has come to our rescue-or has it? Unfortunately, bioinformatics has created its own share of mayhem and confusion, i.e., what software package is best?
As pointed out at the start of this chapter, "leave it to the professionals," i.e., get someone onboard who has some experience in this area. That said, if you go back to the basics, the task will not be as intimidating as first thought. A good start is a book called Bioinformatics for Dummies (Claverie and Notredame 2003) , which as its cover states is "a painless and thorough introduction to the field." As novices, you will require a software package that can: • Identify open reading frames (ORFs). This is classically defined as a string of sequence starting with a start (AUG) and ending with a stop codon (UAG, UAA, or UGA). As some organisms do not exclusively recognize AUG as a start codon, you might want your software to allow you to look at ORFs between two stop codons. • View relevant features in all six possible frames. This allows you to quickly see where the larger ORFs are located on the genome. • Upon selecting an ORF, provide a predicted amino acid sequence. This is an important feature as it gives you the flexibility to search (BLAST) Web-based genomic databases (NCBI, EBI, etc.) for DNA or protein homologs (though you do not need a putative amino acid sequence to conduct homology searches, NCBI will allow you to do all permutations). • Give you these aforementioned features and can perform all these functions in real time, i.e., easily accessible (point and click), integrated software with automated tools and user friendly output formats. We have personal experience with two software packages, namely Artemis (www.sanger.ac.uk/Software/Artemis/) and DNASTAR (www.dnastar.com) (Schroeder et al. 2009; Wilson et al. 2005) . Both are more than suited for custom annotation of viromes, as are many other packages in the market place, so the choice is ultimately up to the user. An alternate strategy for ORF identification is to use automated software such as AMIGene (www.genoscope.cns.fr/agc/tools/amiga/form.php), GLIMMER (www.cbcb.umd.edu/software/glimmer/), and Gen-eMark (http://exon.biology.gatech.edu/)-all of which have been used to annotate the latest giant virus, Feldmannia sp. virus 158 (Schroeder et al. 2009 ).
An important resource to BLAST against is the increasing volume of virus metagenomics data that is now available. Without doubt, metagenomics has revolutionized the study of microbiology and has revealed an incredible amount of genetic diversity, particularly in the marine environment, and in particular among virus communities. The various methodologies of metagenomics have been discussed and reviewed extensively (Allen and Wilson 2008; Delwart 2007; Hall 2007; Handelsman 2004; Kunin et al. 2008; Riesenfeld et al. 2004; Streit and Schmitz 2004; Tringe and Rubin 2005; Wommack et al. 2008) . A useful starting point for metagenomics data can be found at the Community Cyberinfrastructure for Advanced Marine Microbial Ecology Research and Analysis (CAMERA) Web portal (http://camera.calit2. net/). CAMERA is making raw environmental sequence data accessible along with associated metadata, pre-computed search results, and high-performance computational resources.
• Verification of functional assignment (annotation) I) From ORFs to coding sequences (CDS) with putative function: • Phylogeny. ORFs that have a BLAST homolog is likely to be coding for a gene of a putative function, i.e., coding sequences (CDS). CDS homologs identified by the various BLAST outputs should only be considered as indicators of possible function. An important first step in verify puta- tive gene identities is by performing a phylogenetic analysis. Therefore, the analysis is characterized by the threshold cycle (Ct)-the sooner the threshold is reached the higher the starting number of target molecules. Using standard curve samples (DNA for DNA molecules and RNA for RNA molecules) with known concentrations, it is possible to determine the copy number of the molecule in question. • Microarrays. RT-PCR looks at the expression of one gene at a time. Microarrays can carry thousands of gene-specific probes to detect multiple targets in a single sample (Allen and Wilson 2006; Allen et al. 2010, this volume) . Sample cDNA is hybridized to a platform (e.g., a microscope slide) containing spots of DNA (60-70-mer oligonucleotide probes, each diagnostic for a target of interest). In transcriptional microarrays, positive hybridization indicates up-regulation of a gene, hence confirming transcription of a CDS. As an example, microarrays were employed in the annotation of the EhV-86 genome (Wilson et al. 2005) . Functional information from preliminary expression results can be used to determine correct reading frames for disputed CDSs. In addition, it can be used to help to identify new and unannotated CDSs. The primary use of the microarray is to assign virus transcripts into kinetic classes with the distinct aim of helping to determine the function of coordinately expressed genes with no database homologues (Allen et al. 2006a ). An opportunistic use of the microarray is to use it as a tool for genome diversity analysis (Allen et al. 2007 ). Very simply, the array can be used as a hybridization tool to determine presence or absence (or highly divergent) of genes in genomes of related coccolithoviruses. Rather than focusing on a single gene, the microarray will allow the formation of a diversity index based on whole genomes without the need to sequence these genomes. This can help to reveal core coccolithovirus genes and identify variable and absent genes between coccolithovirus genomes (Allen et al. 2006c ). III) From Gene to Protein: • Proteomics. Analysis and characterization of the complete set of proteins (proteome) of a virus is one way to determine if structural genes are eventually translated into proteins (Allen et al. 2008; Clokie et al. 2008) . Currently, the method is not commonly used for aquatic viruses, however it is a promising tool which combines 2D-gel electrophoresis followed by quantitative or semiquantitative mass spectrometry-based analysis of virus proteomes. Analysis of interactions between virus and host proteomes is leading to the new field of interactomics, an emerging area that uses genomic and proteomic tools to determine the full set of interactions between viruses and their hosts (Viswanathan and Fruh 2007) .
Assessment and discussion
The fundamental basis of life is written in nucleic acid. For viruses, this code is written in a variety of forms, be it single-or double-stranded, RNA or DNA. To date, genomic analysis of viruses has had the biggest impact on the study of virus diversity. Regardless of the nature of the genome, the pinnacle of assessing any biological entity's genetic diversity is to sequence its entire genome, then crucially, compare it to other genomes to assess the magnitude of the changes. The best (and most comprehensive) assessment of virus diversity would be to sequence the entire genome of every virus on the planet. This, of course, is beyond the realms of possibility and plausibility. At the time of writing, the viral genomes page on NCBI (www. ncbi.nlm.nih.gov/genomes/GenomesHome.cgi?taxid = 10239) contained links to 3235 reference sequences for 2178 virus genomes and 41 reference sequences for viroids. The vast majority of these viruses are medically or agriculturally related, essentially reflecting the levels of funding for these important areas of research. Only a fraction (1%-2%) of the genomes are from aquatic viruses (Table 1) . However, it is clear from this small but diverse collection of viruses that their hosts are equally diverse and include bacteria, archaea, algae, amoeba, invertebrates, and vertebrates, with virus genomes ranging in size from a few thousand bases to over a million bases.
These fully sequenced viruses represent only a minute fraction of the estimated 10 31 viruses in aquatic environments, yet they have revealed a plethora of novelty and have altered our view of viruses as simple 'bags of genes'. It is common to identify genes involved in core virus functions such as RNA polymerase, DNA polymerase, and structural proteins, yet it Table 1 . Selection of viruses of aquatic origin listed at NCBI that have completed genomes (as of February 2009). NB. The list is not exhaustive, the focus is on viruses that infect primary producers, and the microbial components of aquatic ecosystems. It is worth noting that descriptors for search terms are limited, and it is currently not possible to pull out virus genomes that are of aquatic (either marine or freshwater) origin. As increasing numbers of virus genomes are added to databases, it is important that appropriate metadata, such as proposed by MIGS (Field et al. 2008) , is made available to allow researchers to refine searches for specific groups of genomes. Although the aim of this table is to point the reader in the direction of aquatic virus reference genomes and a virus genome Web portal, the sequencing pipeline for each type of virus (i.e., RNA or DNA) is essentially the same once you have access to an adequate concentration of good quality nucleic acid. Acquiring enough high purity nucleic acid is arguably the biggest challenge of any aquatic virus sequencing project.
Virus
Family Accession* Size Reference has becoming increasingly obvious that most viruses also harbor the ability to alter and manipulate host metabolism in highly specific ways to maximize the chance of successful infection. For example, genes involved in sphingolipid production, photosynthesis, and carbon metabolism have all been identified on virus genomes in recent years (Clokie and Mann 2006; Lindell et al. 2005; Lindell et al. 2004; Mann et al. 2005; Mann et al. 2003; Sandaa et al. 2008; Wilson et al. 2005; Yoshida et al. 2008) . Complete genome sequencing projects are becoming commonplace, yet these projects are still restricted to relatively small numbers of isolates making comparative genomics of viruses still a young science. Preliminary comparative genomic analyses are making promising progress in helping to determine evolutionary and taxonomic status of certain groups of viruses (Allen et al. 2006c; Hendrix et al. 1999; Iyer et al. 2006; Rohwer and Edwards 2002) . Full genome comparisons of aquatic viruses have been completed recently, particularly with algal virus and cyanophage genomes (Allen et al. 2006b; Delaroque et al. 2003; Fitzgerald et al. 2007a; Fitzgerald et al. 2007b; Fitzgerald et al. 2007c; Sullivan et al. 2005) , this can help determine the selective advantage of containing certain genes, especially if a gene is missing in a closely related virus isolate. This allows downstream hypothesis testing with virus host systems to help determine the true function of observed differences between genomes. Despite falling costs and the obvious scientific advantages of having complete coverage, it is often difficult for researchers to justify sequencing closely related viruses (Allen et al. 2006b; Delaroque et al. 2003) . However, subtle differences at the genetic level can have profound effects on the infection success of closely related virus isolates. This diversity often remains hidden within a genome and is not immediately obvious until full genomic sequences become available.
A quick analysis of the size spectrum of genomes reveals a significant gap between the 407kb EhV-86 and the 1,181kb Mimivirus (Table 1) . One explanation is simply lack of isolated representatives in this size range and here lies a methodological conundrum. Viruses in this genome size range are likely to be too large to pass through a 0.2 µm filter. Standard procedure includes passing a water sample through a 0.2µm filter and looking for viruses in the filtrate. However, most large viruses will not be filterable through such a pore size, so even at this early sampling stage, researchers often introduce a size bias in their sampling strategy. Numerous Mimivirus sequence homologs have been identified in the Venter Sargasso Sea environmental database (Ghedin and Claverie 2005; Monier et al. 2008a; Monier et al. 2008b) . Indeed, these authors suggest that their data are indicative of high concentrations of Mimivirus 'relatives' in the ocean. Only a concerted sampling effort to specifically isolate giant viruses in these environments will identify new giant viruses that will fill the gap at the top end of the genome size range.
Certainly the biggest dilemma when trying to choose new viruses to sequence is trying to determine where to start and how to justify some viruses over others? Options for justification could be global importance of the host (clear implications for biogeochemical cycling and gene transfer processes); whether the host is sequenced (useful for downstream postgenomic analysis of virus-host interactions); extraordinary size of virus (help explain why the virus is so large); other virus relatives already sequenced (useful for comparative genomics and evolutionary determination); unusual host niche (does the genetic signature provide clues of a selective advantage in that niche) or exploitation opportunities (viruses from e.g., extreme environments). Whichever isolates are chosen, all will help to answer specific hypotheses as well as give novel information to help generate new questions and hypotheses for future projects. Future advances will involve using tools such as microarrays, proteomics, and interactomics to help determine functionality of unknown genes. Sequence information should be considered as a starting point for asking questions and developing hypotheses about the role of viruses. It is an exciting new era for virus ecology and when used in combination with more traditional approaches, virus genomics will give us access to their ecological function on an unprecedented scale.
Comments and recommendations
Start with as high purity nucleic acid preparation as you can manage. Do not rush it, proceed with care. If your budget can stand it, get as much professional help as you can, particularly with bioinformatics. However, if your budget is limited, there is plenty of user friendly software now available to help build, annotate, and then compare sequence data. But do not give up. Most viruses sequenced to date have produced surprises in their genomes, and there are more to come from the other 99.9999% (or 10 31 ) viruses yet to be sequenced.
